Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Non-Hodgkin's lymphoma is a diverse group of blood cancers that develop when white blood cells called lymphocytes grow abnormally. While the exact cause remains unknown for most patients, Non-Hodgkin's lymphoma results from a complex interplay between acquired genetic mutations, immune system dysregulation, and environmental factors. What causes the development of Non-Hodgkin's lymphoma? In most cases, Non-Hodgkin's lymphoma begins with a mutation in the DNA of a B-cell or T-cell, causing it to divide uncontrollably.
1 people with Non-Hodgkin's lymphoma have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Non-Hodgkin's lymphoma is a diverse group of blood cancers that develop when white blood cells called lymphocytes grow abnormally. While the exact cause remains unknown for most patients, Non-Hodgkin's lymphoma results from a complex interplay between acquired genetic mutations, immune system dysregulation, and environmental factors.
In most cases, Non-Hodgkin's lymphoma begins with a mutation in the DNA of a B-cell or T-cell, causing it to divide uncontrollably. Unlike inherited genetic diseases, these mutations are usually "somatic," meaning they occur during an individual's lifetime rather than being passed down from parents. Researchers are still investigating why these specific cells undergo malignant transformation, though it is understood that the process involves the accumulation of multiple genetic errors that allow the cell to evade the body’s natural checkpoints.
It is important to distinguish between "causes" (the direct trigger) and "risk factors" (elements that increase the probability of developing the disease). While we cannot point to a single cause for most cases of Non-Hodgkin's lymphoma, several well-documented risk factors exist:
Non-Hodgkin's lymphoma is rarely considered a hereditary condition. While there may be a subtle, underlying genetic predisposition in some families, the vast majority of cases are not linked to a single inherited gene mutation. Current research is heavily focused on "genomic profiling" to better understand the specific molecular pathways of Non-Hodgkin's lymphoma, which helps physicians select targeted therapies for the 96 community members and thousands of others managing this diagnosis.
Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.